Karla Esbona1, Zhanhai Li, Lee G Wilke. 1. Department of Molecular and Regenerative Biology, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA.
Abstract
BACKGROUND: Achieving negative surgical margins is critical to minimizing the risk of tumor recurrence in patients undergoing breast conservation surgery (BCS) for a breast malignancy. Our objective was to perform a systematic review comparing reexcision rates, sensitivity and specificity of the intraoperative use of the margin assessment techniques of imprint cytology (IC) and frozen section analysis (FSA), against permanent histopathologic section (PS). METHODS: The databases PubMed, Web of Knowledge, Cochrane Library and CINAHL Plus were searched for literature published from 1997 to 2011. Original investigations of patients who underwent BCS for breast cancer that evaluated margin assessment with PS and/or IC or FSA were included. Of 182 titles identified, 41 patient cohorts from 37 articles met inclusion criteria: PS (n = 19), IC (n = 7) and FSA (n = 15). Studies were summarized qualitatively using the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) checklist for cohort studies and the Strength of Recommendation Taxonomy (SORT) numerical scale for diagnostic studies. RESULTS: The final reexcision rates after primary BCS were 35 % for PS, 11 % for IC (p = 0.001 vs. PS) and 10 % for FSA (p < 0.0001 vs. PS). For IC, reexcision rates decreased from 26 to 4 % (p = 0.18) and for FSA, reexcision rates decreased from 27 to 6 % (p < 0.0001). The pooled sensitivity of IC and FSA were 72 and 83 %. The pooled specificity of IC and FSA were 97 and 95 %. The average length of each technique was 13 min for IC and 27 min for FSA. CONCLUSIONS: Patients who underwent BCS with intraoperative IC or FSA to assess negative surgical margins had significantly fewer secondary surgical procedures for excision of their breast malignancies.
BACKGROUND: Achieving negative surgical margins is critical to minimizing the risk of tumor recurrence in patients undergoing breast conservation surgery (BCS) for a breast malignancy. Our objective was to perform a systematic review comparing reexcision rates, sensitivity and specificity of the intraoperative use of the margin assessment techniques of imprint cytology (IC) and frozen section analysis (FSA), against permanent histopathologic section (PS). METHODS: The databases PubMed, Web of Knowledge, Cochrane Library and CINAHL Plus were searched for literature published from 1997 to 2011. Original investigations of patients who underwent BCS for breast cancer that evaluated margin assessment with PS and/or IC or FSA were included. Of 182 titles identified, 41 patient cohorts from 37 articles met inclusion criteria: PS (n = 19), IC (n = 7) and FSA (n = 15). Studies were summarized qualitatively using the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) checklist for cohort studies and the Strength of Recommendation Taxonomy (SORT) numerical scale for diagnostic studies. RESULTS: The final reexcision rates after primary BCS were 35 % for PS, 11 % for IC (p = 0.001 vs. PS) and 10 % for FSA (p < 0.0001 vs. PS). For IC, reexcision rates decreased from 26 to 4 % (p = 0.18) and for FSA, reexcision rates decreased from 27 to 6 % (p < 0.0001). The pooled sensitivity of IC and FSA were 72 and 83 %. The pooled specificity of IC and FSA were 97 and 95 %. The average length of each technique was 13 min for IC and 27 min for FSA. CONCLUSIONS:Patients who underwent BCS with intraoperative IC or FSA to assess negative surgical margins had significantly fewer secondary surgical procedures for excision of their breast malignancies.
Authors: Mark H Ebell; Jay Siwek; Barry D Weiss; Steven H Woolf; Jeffrey Susman; Bernard Ewigman; Marjorie Bowman Journal: Am Fam Physician Date: 2004-02-01 Impact factor: 3.292
Authors: Philip S Mullenix; Daniel G Cuadrado; Scott R Steele; Matthew J Martin; Craig S See; Alan L Beitler; Preston L Carter Journal: Am J Surg Date: 2004-05 Impact factor: 2.565
Authors: Michael G Giacomelli; Yuri Sheikine; Hilde Vardeh; James L Connolly; James G Fujimoto Journal: Biomed Opt Express Date: 2015-10-08 Impact factor: 3.732
Authors: Yuankai K Tao; Dejun Shen; Yuri Sheikine; Osman O Ahsen; Helen H Wang; Daniel B Schmolze; Nicole B Johnson; Jeffrey S Brooker; Alex E Cable; James L Connolly; James G Fujimoto Journal: Proc Natl Acad Sci U S A Date: 2014-10-13 Impact factor: 11.205
Authors: Wes M Allen; Ken Y Foo; Renate Zilkens; Kelsey M Kennedy; Qi Fang; Lixin Chin; Benjamin F Dessauvagie; Bruce Latham; Christobel M Saunders; Brendan F Kennedy Journal: Biomed Opt Express Date: 2018-11-19 Impact factor: 3.732
Authors: Wes M Allen; Lixin Chin; Philip Wijesinghe; Rodney W Kirk; Bruce Latham; David D Sampson; Christobel M Saunders; Brendan F Kennedy Journal: Biomed Opt Express Date: 2016-09-19 Impact factor: 3.732
Authors: Barbara L Smith; Michele A Gadd; Conor R Lanahan; Upahvan Rai; Rong Tang; Travis Rice-Stitt; Andrea L Merrill; David B Strasfeld; Jorge M Ferrer; Elena F Brachtel; Michelle C Specht Journal: Breast Cancer Res Treat Date: 2018-06-09 Impact factor: 4.872
Authors: Esther Kho; Behdad Dashtbozorg; Lisanne L de Boer; Koen K Van de Vijver; Henricus J C M Sterenborg; Theo J M Ruers Journal: Biomed Opt Express Date: 2019-08-07 Impact factor: 3.732